Literature DB >> 6980896

Clinical studies of a new latex particle agglutination test for detection of Haemophilus influenzae type b polyribose phosphate antigen in serum, cerebrospinal fluid, and urine.

E D Shaw, R J Darker, W E Feldman, B M Gray, L L Pifer, G B Scott.   

Abstract

A new latex particle agglutination test for direct detection of Haemophilus influenzae type b polyribose phosphate antigen in serum, cerebrospinal fluid, or urine was evaluated from studies at four clinical centers. Although use of a serum buffer significantly reduced inconclusive agglutination of the latex particles, the retesting of serum samples, after heat inactivation and dilution, resolved all serum samples, with one exception, as reactive or nonreactive for the presence of the polyribose phosphate antigen. A clinical accuracy of 100% was obtained for the latex particle agglutination method in respect to its capability for detection of polyribose phosphate antigen in all patients with confirmed infection by H. influenzae type b.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980896      PMCID: PMC272270          DOI: 10.1128/jcm.15.6.1153-1156.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  N Engl J Med       Date:  1977-02-24       Impact factor: 91.245

2.  Detection of bacterial antigen in pleural fluid by counterimmunoelectrophoresis.

Authors:  R M Lampe; T Chottipitayasunondh; P Sunakorn
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

3.  Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b.

Authors:  P Anderson; D H Smith
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

4.  Effect of prior antibiotic therapy on concentrations of bacteria in CSF.

Authors:  W E Feldman
Journal:  Am J Dis Child       Date:  1978-07

5.  Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination.

Authors:  H C Whittle; P Tugwell; L J Egler; B M Greenwood
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

6.  Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  M W Bradshaw; R Schneerson; J C Parke; J B Robbins
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

7.  Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis.

Authors:  J I Ward; G R Siber; D W Scheifele; D H Smith
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

8.  Increased sensitivity of a new coagglutination test for rapid identification of Haemophilus influenzae type b.

Authors:  R J Grasso; L A West; N J Holbrook; D G Halkias; L J Paradise; H Friedman
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

9.  Comparison of two antigen detection techniques in a primate model of Haemophilus influenzae type b infection.

Authors:  D W Scheifele; R S Daum; V P Syriopoulou; G R Siber; A L Smith
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

10.  An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.

Authors:  R Schneerson; M Bradshaw; J K Whisnant; R L Myerowitz; J C Parke; J B Robbins
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

  10 in total
  9 in total

1.  Comparison of Phadebact coagglutination, Bactogen latex agglutination, and counterimmunoelectrophoresis for detection of Haemophilus influenzae type b antigens in cerebrospinal fluid.

Authors:  J K Collins; M T Kelly
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

2.  Rapid diagnosis of severe Haemophilus influenzae serotype b infections by monoclonal antibody enzyme immunoassay for outer membrane proteins.

Authors:  A Belmaaza; J Hamel; S Mousseau; S Montplaisir; B R Brodeur
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

3.  Comparative laboratory evaluation of three antigen detection methods for diagnosis of Haemophilus influenzae type b disease.

Authors:  M J Marcon; A C Hamoudi; H J Cannon
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

4.  Haemophilus influenzae type b infection in childhood: history of bacteremia and antigenemia.

Authors:  L J La Scolea; S V Rosales; P L Ogra
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

5.  Detection of Haemophilus influenzae type b antigenuria by Bactigen and Phadebact kits.

Authors:  L Riera
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

6.  Detection of Streptococcus pneumoniae and Haemophilus influenzae type b antigens in acute nonbacteremic pneumonia.

Authors:  S J Martin; D A Hoganson; E T Thomas
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

7.  Commercial latex agglutination tests for detection of Haemophilus influenzae type b and Streptococcus pneumoniae antigens in patients with bacteremic pneumonia.

Authors:  G W Ajello; G A Bolan; P S Hayes; D Lehmann; J Montgomery; J C Feeley; C A Perlino; C V Broome
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

8.  Effect of growth phase on the bactericidal action of chloramphenicol against Haemophilus influenzae type b and Escherichia coli K-1.

Authors:  W E Feldman; N S Manning
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

9.  Comparison of a new, rapid enzyme-linked immunosorbent assay with latex particle agglutination for the detection of Haemophilus influenzae type b infections.

Authors:  A B Macone; G Arakere; J M Letourneau; D A Goldmann
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.